Dr Rodrigo Gutierrez-Quintana receives a 2021 Catalyst Award from Cure Epilepsy
Published: 15 August 2022
Dr Gutierrez-Quintana and his team will test a completely new class of drug targets for epilepsy called microRNAs.
Dr Rodrigo Gutierrez-Quintana is the recipient of a 2021 Catalyst Award from Cure Epilepsy. Dr Gutierrez-Quintana and his team propose to test a completely new class of drug targets for epilepsy called microRNAs. Instead of changing brain excitability, these naturally occurring molecules coordinate signalling processes inside brain cells by controlling expression of various genes. Dr Gutierrez-Quintana’s team will now test the effects of Ant-134 in a population of dogs with naturally occurring drug-resistant epilepsy, an important step towards translating their findings into treatments for humans. If successful, this project will pave the way for human clinical trials for a treatment that has the potential of providing long-lasting seizure control after a single dose and may be even cure some forms of epilepsy.
First published: 15 August 2022
<< News